Navigation Links
CVS Caremark Employees Raise $1 Million and Increase Awareness for Children with Disabilities through Easter Seals Walk With Me Events Nationwide
Date:6/20/2008

WOONSOCKET, R.I., June 20 /PRNewswire/ -- This year, thousands of CVS Caremark associates across the country will participate in Easter Seals Walk With Me events as part of the CVS Caremark All Kids Can(TM) program, one of the country's largest corporate commitments to children with disabilities. Easter Seals was selected as an All Kids Can national partner when the company introduced the program in 2006.

Since 2006, CVS Caremark and its private foundation have contributed more than $4 million to Easter Seals, including CVS Caremark All Kids Can Fund gifts to support Easter Seals autism services, and a commitment to Easter Seals Metropolitan Chicago's Therapeutic Day School and Center for Autism Research, scheduled to open this fall. Additionally, each year CVS Caremark has been a valued sponsor for Easter Seals Walk With Me events and employee teams have shown their support through Walk With Me pledges and local Easter Seals fundraisers.

In Providence, hundreds of CVS Caremark employees will converge at Roger Williams Park Zoo this Saturday to raise money for local children with disabilities. Since 2006, some 7,000 CVS Caremark employees have raised more than $1 million through walks for local Easter Seals affiliates. Walkers in Saturday's event in Providence will include about 350 CVS Caremark employees and their families, who expect to raise more than $75,000 to expand Easter Seals' early intervention services in the state.

"In Rhode Island, 14% of children under 18 have a disability, and nationally, 9.2% of American families with children have at least one child with disability," said Eileen Howard Dunn, Senior Vice President of Corporate Communications and Community Relations, CVS Caremark. "CVS Caremark is committed to improving the lives of children with disabilities through our All Kids Can program. We are very proud that so many of our employees are helping us support Easter Seals in expanding its extraordinary services to even m
'/>"/>

SOURCE CVS Caremark
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. CVS Caremark to Present Insights on Redefining the Consumer Health Care Experience at AHIP Institute 2008
2. CVS Caremark Launches the 2008 Season of the CVS Caremark All Kids Can(TM) Baseball Camps at Fenway Park
3. CVS Caremark Honors Heroes in Womens Health
4. CVS Caremark and JVS Announce Grand Opening of the Boston Regional Learning Center
5. CVS Caremark Charity Classic Golf Tournament Unveils 10th Anniversary Field
6. Easter Seals Receives $1 Million Donation From CVS Caremark Charitable Trust to Enhance Autism Services for Children
7. CVS Caremark Presents at NCOA-ASA Conference on Companys Commitment to Recruiting and Retaining Mature Workers
8. Attorney General Corbett Announces $36.7 Million Multi-State Settlement With CVS/Caremark in National Dosage-Switching Investigation
9. CVS Caremark Corp. to Pay $36.7 Million to U.S., 23 States, & D.C. to Settle Medicaid Prescription Drug Fraud Allegations
10. CVS Caremark All Kids Can Program Announces the Opening of a Boundless(TM) Playground in Dallas to Serve Children of all Abilities
11. Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Caremark
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Cambodia 3A World AIDS Day HIV Campaign Testing Millions to Again Launch During Cambodias National Water Festival 60453 1Cambodia 3A World AIDS Day HIV Campaign Testing Millions to Again Launch During Cambodias National Water Festival 60453 2Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 1Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 2Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 3NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 1NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 2NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 3